Marginal zone lymphomas (MZL) are collectively the second most common indolent
lymphoma comprising 7% of all non-Hodgkin lymphomas with 7,460 patients diagnosed in …

Session 3 of the lymphoma workshop of the XXI joint meeting of the European Association
for Haematopathology and the Society for Hematopathology took place in Florence, Italy, on …

Disease overview Marginal zone lymphomas (MZL) are collectively the second most
common type of indolent lymphoma. Diagnosis Three subtypes of MZL are recognized …

Abstract The t (14; 19)(q32; q13) often juxtaposes BCL3 with immunoglobulin heavy chain
(IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations …

Some patients with marginal zone lymphoma (MZL) experience histological transformation
to diffuse large B‐cell lymphoma (DLBCL). Because of the paucity of long‐term data on …

The genetic mechanisms associated with splenic marginal zone lymphoma (SMZL)
transformation are not well defined. We studied 41 patients with SMZL that eventually …

Histological transformation of marginal zone lymphoma (tMZL) into diffuse large B-cell
lymphoma is associated with poor outcomes. Clinical characteristics associated with …

Marginal zone lymphomas (MZLs) represent about 7% of B-cell non-Hodgkin lymphomas
and include 3 different subtypes—namely, extranodal (EMZL), nodal, and splenic (SMZL) …

Histological transformation into an aggressive B-cell lymphoma indicates a poor survival
outcome for patients with indolent marginal zone lymphoma (MZL), which has been less …

Marginal zone lymphoma (MZL) includes extranodal (EMZL), splenic (SMZL), and nodal
(NMZL) subtypes. Histological transformation (HT) to large B-cell lymphomas is well …